Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Return on Invested Capital (2021 - 2025)

Agilon Health's Return on Invested Capital history spans 5 years, with the latest figure at 1.85% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 134.0% year-over-year to 1.85%; the TTM value through Dec 2025 reached 1.85%, down 134.0%, while the annual FY2025 figure was 1.33%, 86.0% down from the prior year.
  • Return on Invested Capital reached 1.85% in Q4 2025 per AGL's latest filing, down from 1.01% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.22% in Q1 2021 to a low of 1.85% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.42%, with a median of 0.34% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: soared 77bps in 2022, then crashed -134bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.33% in 2021, then soared by 70bps to 0.1% in 2022, then plummeted by -188bps to 0.29% in 2023, then tumbled by -77bps to 0.51% in 2024, then tumbled by -260bps to 1.85% in 2025.
  • Per Business Quant, the three most recent readings for AGL's Return on Invested Capital are 1.85% (Q4 2025), 1.01% (Q3 2025), and 0.73% (Q2 2025).